Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Antimicrobial Agents and Chemotherapy|June 28, 2021
Detection of Pyrazinamide Heteroresistance in Mycobacterium tuberculosisJim Werngren, Mikael Mansjö, Mikaela Glader, et al.
Microorganisms|July 29, 2023
The Relative Positioning of Genotyping and Phenotyping for Tuberculosis Resistance Screening in Two EU National Reference Laboratories in 2023Richard Anthony, Ramona Groenheit, Mikael Mansjö, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2024
Performance of a broth microdilution assay for routine minimum inhibitory concentration determination of 14 anti-tuberculous drugs against the Mycobacterium tuberculosis complex based on the EUCAST reference protocolMikael Mansjö, Carmen Espinosa-Gongora, Ishak Samanci, et al.
Antimicrobial Agents and Chemotherapy|November 21, 2022
The ddn Trp20Stop Mutation and Its Association with Lineage 4.5 and Resistance to Delamanid and Pretomanid in Mycobacterium tuberculosisMikael Mansjö, Oskar Karlsson Lindsjö, Christina Grönfors Seeth, et al.
Plos One|June 24, 2011
Dynamics of antibiotic resistant Mycobacterium tuberculosis during long-term infection and antibiotic treatmentSolomon H Mariam, Jim Werngren, Joakim Aronsson, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 1, 2019
Non-commercial phenotypic assays for the detection of Mycobacterium tuberculosis drug resistance: a systematic reviewIrina Kontsevaya, Jim Werngren, Yen Holicka, et al.
Biochimica Et Biophysica Acta|March 15, 2016
Ebselen and analogs as inhibitors of Bacillus anthracis thioredoxin reductase and bactericidal antibacterials targeting Bacillus species, Staphylococcus aureus and Mycobacterium tuberculosisTomas N Gustafsson, Harer Osman, Jim Werngren, et al.
BMC Infectious Diseases|January 8, 2016
Drug resistance characteristics and cluster analysis of M. tuberculosis in Chinese patients with multiple episodes of anti-tuberculosis treatmentYi Hu, Qi Zhao, Jim Werngren, et al.
Antimicrobial Agents and Chemotherapy|March 16, 2021
Atypical Genetic Basis of Pyrazinamide Resistance in Monoresistant Mycobacterium tuberculosisSamuel J Modlin, Tyler Marbach, Jim Werngren, et al.
Antimicrobial Agents and Chemotherapy|April 30, 2014
In vitro activity of AZD5847 against geographically diverse clinical isolates of Mycobacterium tuberculosisJim Werngren, Maria Wijkander, Nasrin Perskvist, et al.
Pageof 6